Wendy W. Tu, MD
**-** **** **., ***** *B Cell: 718-***-****
Flushing, NY 11354 Email: ***********@*******.***
With more than 5 years healthcare experience including 3 years in Clinical Research (Phase IV study)
Therapeutic Areas
Oncology, infectious diseases, and internal medicine
Professional Experience
Physician’s Assistant - AE & LY Medical Associates, PLLC, Long Island, NY June 2012 - Present
• Provided consultation to internal and GI patients
• Charted medical records
• Performed medical term coding
• Reported adverse events to regulatory authorities (MedWatch form)
• Communicated with pharmaceutical representatives and followed-up with patients on adverse events
• Assisted in colonoscopy and endoscopy procedures
• Maintained compliance with regulations on infectious diseases that would impact public health
• Participated in weekly internal team meetings
Medical Technology Specialist - NewPath Diagnostics, LLC, Flushing, NY Sept. 2010 - June 2012
• Performed diagnosis tests for bladder cancer (FISH)
• Performed laboratory tests including chemistry, immunology, hematology, and urine analysis
• Responsible for data management
• Maintained compliance with SOPs
• Performed quality control
• Trained new staff on SOPs, quality assurance, and data entry
• Prepared pathology slides for medical review
• Communicated with clinical physicians about emergency test results
• Managed documents, specimens, and pathology slides
Residency/Post-Doctorate Research Fellow – Huadong Hospital, Fudan University, Shanghai, China
Sept. 2007 – July. 2010
• Residency in Internal Medicine
• Specialized in Infectious Disease diagnosis and treatment
• Participated in study design of a Phase IV clinical trial; Double-blind, Open Label Study of the Adverse Effects of Carbapenem and β-Lactam on the Acceleration of AmpC β-Lactamase Expression Post Lower Respiratory Infections
• Prepared study proposal for grant application
• Performed study monitoring including patient screening & enrollment
• Conducted safety monitoring including adverse event recording, treatment, and reporting
• Project management including study drug management, timeline, grant management, and supervision of study coordinators
• Conducted study data collection and performed data analysis
• Prepared manuscript for publication
• Presented study results at a national conference
Computer Literacy
Word, Excel, PowerPoint, Social Network, and Databases (MDLand, NewPath Data, and EMR)
Education & Professional Training
Medical Doctorate, MD Sept. 2002 - June 2007
Sun Yat-Sen University, Guangdong, China
Resident/ Clinical Research Fellow Sept. 2007 – June 2010
Infectious Diseases
Fudan University, Shanghai, China
Honors and Awards
• Graduated with Honors from Sun Yat-Sen University, China 2007
• Scholarship from Sun Yat-Sen University, China 2002-2004
Publications
• Double-blind, Open Label Study of the Adverse Effects of Carbapenem and β-Lactam on the Acceleration of AmpC β-Lactamase Expression Post Lower Respiratory Infections. Chinese Journal of Nosocomiology, 2010, 20(10): 5-7.
• Specific Mutations of AmpD Gene Leading to the Emergence of Derepressed High-Productive AmpC β-Lactamase. International Journal of Laboratory Medicine, 2010, 31(1): 4-7.
• Molecular Biological Research Progress of AmpC β-Lactamase. Journal of Medical Laboratory Sciences, 2009, 24(11): 854-858.
References
Available upon request.